Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II trial

Steven R. Alberts, Mark Schroeder, Charles Erlichman, Preston D. Steen, Nathan R. Foster, Dennis F. Moore, Kendrith M. Rowland, Suresh Nair, Loren K. Tschetter, Tom R. Fitch

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences